European Medicines Agency workshop on slowing the progression of neurodegenerative diseases

This workshop is involving a panel of European experts actively involved in the clinical research of disease modifiers for neurodegenerative diseases. The workshop is allowing participants to convey their respective views and identify a common ground of enrichment between researchers and regulators.